High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease

<p><strong>Foundation:</strong> High-sensitivity C-reactive protein and homocysteine seem to be related to ischemic cerebrovascular disease, but their findings on the risk and prognosis of this disease are controversial and inconclusive.<br /><strong>Objective:</stro...

Full description

Bibliographic Details
Main Authors: Marisol Peña Sánchez, Cesarina Lisselotte Torres Vázquez, Melany Betancourt Loza, Alina González-Quevedo Monteagudo, Marianela Arteche Prior, María Caridad Menéndez Saiz
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2024-02-01
Series:Medisur
Subjects:
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/5873
_version_ 1797277665422475264
author Marisol Peña Sánchez
Cesarina Lisselotte Torres Vázquez
Melany Betancourt Loza
Alina González-Quevedo Monteagudo
Marianela Arteche Prior
María Caridad Menéndez Saiz
author_facet Marisol Peña Sánchez
Cesarina Lisselotte Torres Vázquez
Melany Betancourt Loza
Alina González-Quevedo Monteagudo
Marianela Arteche Prior
María Caridad Menéndez Saiz
author_sort Marisol Peña Sánchez
collection DOAJ
description <p><strong>Foundation:</strong> High-sensitivity C-reactive protein and homocysteine seem to be related to ischemic cerebrovascular disease, but their findings on the risk and prognosis of this disease are controversial and inconclusive.<br /><strong>Objective:</strong> to characterize high sensitivity C-reactive protein and homocysteine in patients with ischemic cerebrovascular disease. <strong><br />Methods:</strong> a descriptive and retrospective cross-sectional study was carried out in patients with ischemic cerebrovascular disease, admitted to the Stroke Service of the Neurology and Neurosurgery Institute between 2016 and 2019. Demographic variables, clinical manifestations, time of evolution, etiology and infarction location, risk factors. High-sensitivity C-reactive protein (cardiovascular risk) and homocysteine were quantified.<br /><strong>Results:</strong> the means of C-reactive protein (7.0±8.3 mg/L) and homocysteine (17.1±7.3 µM) were high. Moderate and high cardiovascular risk occurred in equal proportions (46.8%). There were statistical differences in the relationship between cardiovascular risk and age (p=0.00); but neither the time of evolution nor the risk factors of the disease showed this behavior. Patients with high cardiovascular risk (hs-CRP &gt;3 mg/L) and high homocysteine (&gt;15 M), exhibited higher frequencies of atherothrombotic or cardioembolic etiologies.<br /><strong>Conclusions:</strong> cardiovascular risk increases as the age of patients with ischemic cerebrovascular disease increases. Demographic, clinical and neurological characteristics did not show a relationship with high cardiovascular risk and high homocysteine values, although an associative trend of atherothrombotic etiology was found with increased high-sensitivity C-reactive protein and homocysteine.</p>
first_indexed 2024-03-07T15:52:35Z
format Article
id doaj.art-c1630ff06e9c4aa981fc70f9c8032e64
institution Directory Open Access Journal
issn 1727-897X
language Spanish
last_indexed 2024-03-07T15:52:35Z
publishDate 2024-02-01
publisher Centro Provincial de Información de Ciencias Médicas. Cienfuegos
record_format Article
series Medisur
spelling doaj.art-c1630ff06e9c4aa981fc70f9c8032e642024-03-04T23:09:56ZspaCentro Provincial de Información de Ciencias Médicas. CienfuegosMedisur1727-897X2024-02-0122183932458High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular diseaseMarisol Peña Sánchez0Cesarina Lisselotte Torres Vázquez1Melany Betancourt Loza2Alina González-Quevedo Monteagudo3Marianela Arteche Prior4María Caridad Menéndez Saiz5Instituto de Neurología y Neurocirugía. La Habana, Cuba.Instituto de Neurología y Neurocirugía. La Habana, Cuba.Instituto de Neurología y Neurocirugía. La Habana, Cuba.Instituto de Neurología y Neurocirugía. La Habana, Cuba.Instituto de Neurología y Neurocirugía. La Habana, Cuba.Instituto de Neurología y Neurocirugía. La Habana, Cuba.<p><strong>Foundation:</strong> High-sensitivity C-reactive protein and homocysteine seem to be related to ischemic cerebrovascular disease, but their findings on the risk and prognosis of this disease are controversial and inconclusive.<br /><strong>Objective:</strong> to characterize high sensitivity C-reactive protein and homocysteine in patients with ischemic cerebrovascular disease. <strong><br />Methods:</strong> a descriptive and retrospective cross-sectional study was carried out in patients with ischemic cerebrovascular disease, admitted to the Stroke Service of the Neurology and Neurosurgery Institute between 2016 and 2019. Demographic variables, clinical manifestations, time of evolution, etiology and infarction location, risk factors. High-sensitivity C-reactive protein (cardiovascular risk) and homocysteine were quantified.<br /><strong>Results:</strong> the means of C-reactive protein (7.0±8.3 mg/L) and homocysteine (17.1±7.3 µM) were high. Moderate and high cardiovascular risk occurred in equal proportions (46.8%). There were statistical differences in the relationship between cardiovascular risk and age (p=0.00); but neither the time of evolution nor the risk factors of the disease showed this behavior. Patients with high cardiovascular risk (hs-CRP &gt;3 mg/L) and high homocysteine (&gt;15 M), exhibited higher frequencies of atherothrombotic or cardioembolic etiologies.<br /><strong>Conclusions:</strong> cardiovascular risk increases as the age of patients with ischemic cerebrovascular disease increases. Demographic, clinical and neurological characteristics did not show a relationship with high cardiovascular risk and high homocysteine values, although an associative trend of atherothrombotic etiology was found with increased high-sensitivity C-reactive protein and homocysteine.</p>http://medisur.sld.cu/index.php/medisur/article/view/5873accidente cerebrovascular isquémicoproteína c reactivahomocisteína
spellingShingle Marisol Peña Sánchez
Cesarina Lisselotte Torres Vázquez
Melany Betancourt Loza
Alina González-Quevedo Monteagudo
Marianela Arteche Prior
María Caridad Menéndez Saiz
High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease
Medisur
accidente cerebrovascular isquémico
proteína c reactiva
homocisteína
title High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease
title_full High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease
title_fullStr High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease
title_full_unstemmed High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease
title_short High sensitivity c-reactive protein and homocysteine in patients with ischemic cerebrovascular disease
title_sort high sensitivity c reactive protein and homocysteine in patients with ischemic cerebrovascular disease
topic accidente cerebrovascular isquémico
proteína c reactiva
homocisteína
url http://medisur.sld.cu/index.php/medisur/article/view/5873
work_keys_str_mv AT marisolpenasanchez highsensitivitycreactiveproteinandhomocysteineinpatientswithischemiccerebrovasculardisease
AT cesarinalisselottetorresvazquez highsensitivitycreactiveproteinandhomocysteineinpatientswithischemiccerebrovasculardisease
AT melanybetancourtloza highsensitivitycreactiveproteinandhomocysteineinpatientswithischemiccerebrovasculardisease
AT alinagonzalezquevedomonteagudo highsensitivitycreactiveproteinandhomocysteineinpatientswithischemiccerebrovasculardisease
AT marianelaartecheprior highsensitivitycreactiveproteinandhomocysteineinpatientswithischemiccerebrovasculardisease
AT mariacaridadmenendezsaiz highsensitivitycreactiveproteinandhomocysteineinpatientswithischemiccerebrovasculardisease